Geode Capital Management
LLY icon

Geode Capital Management’s Eli Lilly LLY Stock Holding History

Geode Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5B Buy
20,191,864
+381,799
+2% +$387M 1.15% 11
2025
Q4 		$21.2B Sell
19,810,065
-7,822
-0% -$7.48M 1.31% 10
2025
Q3 		$15.1B Buy
19,817,887
+1,689,260
+9% +$1.26B 0.96% 12
2025
Q2 		$14.1B Sell
18,128,627
-397,622
-2% -$309M 0.99% 13
2025
Q1 		$15.3B Buy
18,526,249
+1,143,403
+7% +$951M 1.2% 11
2024
Q4 		$13.4B Buy
17,382,846
+291,875
+2% +$242M 1.04% 12
2024
Q3 		$15.1B Buy
17,090,971
+85,823
+0.5% +$77.2M 1.22% 11
2024
Q2 		$15.4B Buy
17,005,148
+429,952
+3% +$344M 1.35% 8
2024
Q1 		$12.9B Buy
16,575,196
+619,557
+4% +$441M 1.19% 9
2023
Q4 		$9.28B Buy
15,955,639
+241,414
+2% +$141M 0.97% 13
2023
Q3 		$8.42B Buy
15,714,225
+508,724
+3% +$262M 1% 12
2023
Q2 		$7.11B Buy
15,205,501
+338,077
+2% +$142M 0.84% 16
2023
Q1 		$5.09B Buy
14,867,424
+159,964
+1% +$53.9M 0.66% 21
2022
Q4 		$5.37B Sell
14,707,460
-1,383,789
-9% -$491M 0.75% 21
2022
Q3 		$5.2B Buy
16,091,249
+373,938
+2% +$118M 0.79% 16
2022
Q2 		$5.09B Buy
15,717,311
+405,075
+3% +$122M 0.75% 18
2022
Q1 		$4.37B Buy
15,312,236
+581,068
+4% +$150M 0.55% 24
2021
Q4 		$4.06B Buy
14,731,168
+409,009
+3% +$104M 0.49% 29
2021
Q3 		$3.3B Buy
14,322,159
+357,886
+3% +$88.3M 0.44% 34
2021
Q2 		$3.2B Buy
13,964,273
+564,757
+4% +$113M 0.44% 35
2021
Q1 		$2.5B Buy
13,399,516
+221,092
+2% +$43.2M 0.38% 44
2020
Q4 		$2.22B Buy
13,178,424
+1,214,688
+10% +$181M 0.37% 48
2020
Q3 		$1.77B Sell
11,963,736
-648,327
-5% -$100M 0.35% 54
2020
Q2 		$2.07B Sell
12,612,063
-35,594
-0.3% -$5.46M 0.44% 38
2020
Q1 		$1.75B Buy
12,647,657
+270,650
+2% +$37.2M 0.46% 40
2019
Q4 		$1.62B Buy
12,377,007
+226,620
+2% +$26.3M 0.34% 59
2019
Q3 		$1.36B Sell
12,150,387
-397,850
-3% -$44.3M 0.32% 60
2019
Q2 		$1.39B Buy
12,548,237
+276,741
+2% +$32.6M 0.34% 56
2019
Q1 		$1.59B Sell
12,271,496
-836,506
-6% -$102M 0.41% 45
2018
Q4 		$1.51B Buy
13,108,002
+830,689
+7% +$92.8M 0.47% 37
2018
Q3 		$1.32B Buy
12,277,313
+547,633
+5% +$54.8M 0.37% 53
2018
Q2 		$999M Buy
11,729,680
+1,229,984
+12% +$101M 0.31% 61
2018
Q1 		$810M Buy
10,499,696
+644,732
+7% +$51.9M 0.26% 72
2017
Q4 		$831M Buy
9,854,964
+406,812
+4% +$34.6M 0.28% 67
2017
Q3 		$807M Buy
9,448,152
+210,087
+2% +$17.2M 0.3% 61
2017
Q2 		$759M Buy
9,238,065
+134,090
+1% +$10.9M 0.3% 64
2017
Q1 		$765M Buy
9,103,975
+708,597
+8% +$56.8M 0.31% 59
2016
Q4 		$617M Sell
8,395,378
-347,044
-4% -$25.8M 0.29% 65
2016
Q3 		$701M Buy
8,742,422
+384,508
+5% +$30.8M 0.35% 52
2016
Q2 		$657M Sell
8,357,914
-28,151
-0.3% -$2.12M 0.36% 50
2016
Q1 		$603K Buy
8,386,065
+392,798
+5% +$29.7M 0.32% 58
2015
Q4 		$672M Buy
7,993,267
+185,147
+2% +$15.4M 0.38% 50
2015
Q3 		$652M Buy
7,808,120
+38,385
+0.5% +$3.24M 0.4% 50
2015
Q2 		$647M Sell
7,769,735
-273,949
-3% -$20.9M 0.37% 53
2015
Q1 		$584M Buy
8,043,684
+221,367
+3% +$15.8M 0.33% 57
2014
Q4 		$539M Buy
7,822,317
+318,137
+4% +$21.5M 0.32% 61
2014
Q3 		$486M Sell
7,504,180
-33,415
-0.4% -$2.12M 0.32% 58
2014
Q2 		$468M Sell
7,537,595
-52,774
-0.7% -$3.15M 0.3% 68
2014
Q1 		$447M Buy
7,590,369
+80,585
+1% +$4.5M 0.3% 68
2013
Q4 		$383M Buy
7,509,784
+393,848
+6% +$19.7M 0.27% 78
2013
Q3 		$358M Buy
7,115,936
+204,974
+3% +$10.7M 0.29% 74
2013
Q2 		$339M Buy
+6,910,962
New +$376M 0.3% 70

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management's LLY Position: Q1 2026 in Review

Geode Capital Management increased its Eli Lilly (LLY) stake by 1.9% in Q1 2026, buying an estimated $387M and bringing the position to 20,191,864 shares worth $18.5B. The position accounts for 1.15% of the portfolio, ranked #11.

Geode Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.2B in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Geode Capital Management held 20,191,864 shares of Eli Lilly worth $18.5B as of Q1 2026.
  • Geode Capital Management bought 381,799 Eli Lilly shares in Q1 2026, an estimated $387M.
  • Eli Lilly made up 1.15% of Geode Capital Management's portfolio in Q1 2026, its #11 holding.
  • Geode Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Eli Lilly position peaked at $21.2B in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.